Description

Introduction DAPAVILDA MET 10/100/1000 is an advanced anti-diabetic formulation containing Dapagliflozin 10 mg + Vildagliptin SR 100 mg + Metformin SR 1000 mg Tablets. This powerful triple combination is specially designed for patients living with Type 2 Diabetes who need stronger blood sugar control, better HbA1c management, and long-term metabolic support. DAPAVILDA MET combines three proven mechanisms in one tablet to help manage fasting blood sugar, post-meal glucose spikes, insulin resistance, and overall glycemic control. It is commonly prescribed when single-drug or dual-drug therapy does not provide adequate diabetes control. This medicine is often searched using keywords like “Dapagliflozin Vildagliptin Metformin Tablets,” “Triple Combination Anti Diabetic Tablets,” and “Best Type 2 Diabetes Control Tablets.” Uses 1. Type 2 Diabetes Management DAPAVILDA MET is primarily used in the treatment of Type 2 Diabetes. It helps maintain healthy blood glucose levels in adult diabetic patients. 2. Blood Sugar Control This medicine effectively controls: Fasting blood sugar Post-meal sugar spikes Long-term glucose fluctuations It helps patients achieve better day-to-day glycemic balance. 3. HbA1c Reduction Regular use under medical supervision may help reduce HbA1c levels, an important marker of long-term diabetes control. 4. Insulin Resistance Management It improves insulin sensitivity, helping the body use insulin more effectively. 5. Metabolic Health Support The combination supports metabolic function and may assist in weight and cardiovascular risk management in selected patients. Benefits Triple Mechanism Action 1. Dapagliflozin Action Dapagliflozin helps remove excess glucose through urine by acting on the kidneys. 2. Vildagliptin Action Vildagliptin increases incretin hormone activity, supporting insulin secretion. 3. Metformin Action Metformin reduces liver glucose production and improves insulin sensitivity. Major Benefits Include: Better blood sugar control Improved HbA1c levels Reduced glucose spikes Enhanced insulin sensitivity Long-lasting SR action Convenient once-daily therapy in many cases Dosage DAPAVILDA MET should always be taken exactly as prescribed by your doctor. General Usage Guidelines: Usually taken with meals to reduce stomach discomfort Swallow whole with water Do not crush or break sustained-release tablets Take at the same time each day Dosage may vary depending on: Blood sugar levels Kidney function Previous diabetes medications Overall health condition Never change the dose without medical advice. Side Effects Like all medicines, DAPAVILDA MET may cause side effects in some patients. Common Side Effects Nausea Stomach discomfort Increased urination Mild dehydration Weakness Headache Less Common Side Effects Urinary tract infection Low blood sugar (in combination with other medicines) Digestive upset Rare but Serious Side Effects Severe dehydration Kidney function changes Allergic reactions Seek immediate medical attention if severe symptoms appear. Precautions and Warnings Before using DAPAVILDA MET, inform your doctor if you have: Kidney disease Liver disease Heart disease Severe dehydration History of recurrent infections Special Precautions: Monitor blood sugar regularly Stay well hydrated Avoid excessive alcohol consumption Regular kidney function testing may be required Follow diet and exercise recommendations Pregnancy and Breastfeeding Use only under medical supervision during pregnancy or breastfeeding. Conclusion DAPAVILDA MET 10/100/1000 containing Dapagliflozin + Vildagliptin + Metformin is an advanced triple-combination therapy designed for effective Type 2 Diabetes management. With its triple-action formula, it helps control fasting sugar, post-meal glucose, insulin resistance, and HbA1c levels while supporting long-term metabolic health. Under proper medical supervision, DAPAVILDA MET can be an effective option for patients needing stronger diabetes management and better quality of life.